- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BNTX
Recent news which mentions BNTX
Switzerland To Dispose 10M Expired COVID-19 Vaccine Doses From Moderna
September 26, 2022
From Benzinga
Health official says updated COVID-19 boosters likely to be available in weeks for elementary school-age children
September 22, 2022
From MarketWatch
Why Is Novavax (NVAX) Stock Falling Today?
September 22, 2022
From InvestorPlace
From MarketWatch
Nikola, Super Micro Computer And Other Big Losers From Monday
September 20, 2022
From Benzinga
Vaccine Stocks: Down but Not Out?
September 19, 2022
From Motley Fool
Why Moderna Stock Dropped Today
September 19, 2022
From Motley Fool
Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today?
September 19, 2022
From InvestorPlace
Health experts dismayed by President Biden’s view that the pandemic is over: ‘Hell no — not even close’
September 19, 2022
From MarketWatch
Why BioNTech, Moderna And Novavax Shares Are Diving
September 19, 2022
From Benzinga
Pfizer Starts Pivotal Phase 3 Study of mRNA-Based Influenza Vaccine
September 14, 2022
From Benzinga
U.S. known COVID cases hold at lowest level since May, but infections are rising again in New York
September 13, 2022
From MarketWatch
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
From Benzinga
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
September 09, 2022
From Benzinga
Why Novavax Stock Sank to a New 52-Week Low Today
September 06, 2022
From Motley Fool
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
September 06, 2022
From Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
September 02, 2022
From Benzinga
COVID boosters that target dominant omicron strains set to start in coming days after CDC gives its OK
September 02, 2022
From MarketWatch
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
September 01, 2022
From Benzinga
Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines
September 01, 2022
From Benzinga
Has it been two months since your last COVID-19 shot? You may soon qualify for a newly designed booster
September 01, 2022
From MarketWatch
2 Big Red Flags and 1 Small Green Flag For Pfizer Stock
September 01, 2022
From Motley Fool
From Benzinga
Why Novavax Stock Got Pummeled Today
August 31, 2022
From Motley Fool
Why Moderna Stock Slumped on Wednesday
August 31, 2022
From Motley Fool
From Benzinga
U.S. life expectancy saw the biggest two-year decline during COVID in almost a century, report finds
August 31, 2022
From MarketWatch
Should Pfizer Investors Be Worried About Moderna's Lawsuits?
August 31, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.